All combination peptide protocols described below are off-label and have not been studied at scale in controlled clinical trials
As William Miller, CEO of Villya Pharmaceuticals and inventor of our patented technology (WO 2025/064695 A1), I appreciate the discussion around Lillys groundbreaking work in the GLP-1 space
Common GLP-1 Medications Explained Several GLP-1 medications are approved for use in the United States, including: Ozempic (semaglutide) Wegovy (also semaglutide, prescribed for weight management), Trulicity (dulaglutide) Victoza (liraglutide) These are available as weekly or daily injections and have seen a surge in demand, as new studies validate not just their effectiveness for diabetes but also for aiding weight loss
Managing Nausea-Related Oral Health Risks For patients experiencing frequent nausea or vomiting, specific strategies can minimize damage to teeth from acid exposure
Impacts among markets differ due to factors including differences in the current obesity rates and future expected obesity trends, medication uptake (cost and eligibility), and the cause-of-death mix
Include all lone pairs and formal charges